• Profile
Close

Improvement in postoperative pain control by combined use of intravenous dexamethasone with intravenous dexmedetomidine after interscalene brachial plexus block for arthroscopic shoulder surgery: A randomised controlled trial

European Journal of Anaesthesiology Apr 08, 2019

Kang RA, et al. - In this randomised controlled study, researchers compared combined use of intravenous dexamethasone and intravenous dexmedetomidine vs intravenous dexamethasone alone, in terms of time to first rescue analgesic request, in 66 patients undergoing arthroscopic shoulder surgery with single-shot interscalene brachial plexus block (ISBPB). Using random assignment, participants received either intravenous 0.9% saline (control), or intravenous dexamethasone 0.11 mg kg−1 (D1 group), or co-administered intravenous dexamethasone 0.11 mg kg−1 and intravenous dexmedetomidine 1.0 μg kg−1 (D2 group). Findings revealed that time to first rescue analgesic request after single-shot ISBPB was significantly prolonged in patients who received co-administered intravenous dexamethasone (0.11 mg kg−1) with dexmedetomidine (1.0 μg kg−1).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay